Package 69097-917-02

{"route": ["ORAL"], "spl_id": "c1d5cac6-7ca2-4b55-90c3-5ef51df0a1ee", "openfda": {"upc": ["0369097918071", "0369097917074"], "unii": ["ZG7E5POY8O"], "rxcui": ["993687", "993691"], "spl_set_id": ["e4100232-a25d-4468-9057-af7e66205154"], "manufacturer_name": ["CIPLA USA INC.,"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (69097-917-02)", "package_ndc": "69097-917-02", "marketing_start_date": "20180526"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (69097-917-07)", "package_ndc": "69097-917-07", "marketing_start_date": "20180526"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (69097-917-15)", "package_ndc": "69097-917-15", "marketing_start_date": "20180526"}], "brand_name": "bupropion Hydrochloride", "product_id": "69097-917_c1d5cac6-7ca2-4b55-90c3-5ef51df0a1ee", "dosage_form": "TABLET", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "69097-917", "generic_name": "bupropion Hydrochloride", "labeler_name": "CIPLA USA INC.,", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "75 mg/1"}], "application_number": "ANDA207389", "marketing_category": "ANDA", "marketing_start_date": "20180526", "listing_expiration_date": "20261231"}